论文部分内容阅读
目的 观察和比较去甲氧柔红霉素治疗急性的初治、复发以及难治性白血病的临床疗效.方法34例急性白血病应用去甲氧柔红霉素辅以其它药物的联合化疗,分为初治组、复发组和难治组三组进行疗效观察比较.结果总有效率达70.6%,初治组与复发组疗效比较有显著性差异(P<0.05),初治组与难治组比较疗效有显著性差异(P<0.01).结论 去甲氧柔红霉素是一种新型、有效的治疗急性白血病的药物.
Objective To observe and compare the clinical efficacy of methoxydroxamicin in the treatment of acute untreated, relapsed and refractory leukemia. Methods 34 patients with acute leukemia were treated with methoxydoxorubicin combined with other drugs. The initial treatment group, the relapse group and the refractory group were compared to observe the curative effect. The total effective rate was 70.6%. There was a significant difference in the curative effect between the initial treatment group and the relapse group (P<0.05). There was a significant difference in the curative effect (P<0.01). Conclusions The idarubicin is a novel and effective drug for the treatment of acute leukemia.